Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
74
TME Quote, Financials, Valuation and Earnings
Last price:
$22.33
Seasonality move
:
-17.19%
Day range:
$21.11 - $21.64
52-week range:
$9.41 - $21.64
Dividend yield:
1.48%
P/E ratio:
25.31x
P/S ratio:
8.32x
P/B ratio:
3.28x
Volume:
4.6M
Avg. volume:
6.3M
1-year change:
41.71%
Market cap:
$33B
Revenue:
$4B
EPS (TTM):
$0.85
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.2B | $4.8B | $4.2B | $3.9B | $4B | |
| Revenue Growth (YoY) | 14.73% | 14.55% | -12.81% | -7.01% | 0.89% | |
| Cost of Revenues | $2.9B | $3.4B | $2.9B | $2.5B | $2.3B | |
| Gross Profit | $1.3B | $1.5B | $1.3B | $1.4B | $1.7B | |
| Gross Profit Margin | 31.91% | 30.1% | 30.96% | 35.3% | 42.34% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $808M | $1B | $827.3M | $709.4M | $651.7M | |
| Other Inc / (Exp) | $20M | $17.3M | $36.5M | $20.5M | $28M | |
| Operating Expenses | $772.5M | $974.8M | $780.3M | $681.8M | $639.1M | |
| Operating Income | $575.4M | $481.7M | $525.8M | $702.9M | $1B | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $671.2M | $562.5M | $651M | $854.6M | $1.2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $66.1M | $64.6M | $79.5M | $116.6M | $223.4M | |
| Net Income to Company | $671.2M | $562.5M | $651M | $854.6M | $1.2B | |
| Minority Interest in Earnings | -$3M | -$28.8M | -$24.1M | -$42.4M | -$64.8M | |
| Net Income to Common Excl Extra Items | $602.1M | $469.1M | $547.4M | $695.5M | $925.9M | |
| Basic EPS (Cont. Ops) | $0.36 | $0.28 | $0.34 | $0.45 | $0.60 | |
| Diluted EPS (Cont. Ops) | $0.36 | $0.28 | $0.34 | $0.44 | $0.59 | |
| Weighted Average Basic Share | $1.7B | $1.7B | $1.6B | $1.6B | $1.5B | |
| Weighted Average Diluted Share | $1.7B | $1.7B | $1.6B | $1.6B | $1.6B | |
| EBITDA | $804.9M | $736.1M | $840.8M | $1B | $1.4B | |
| EBIT | $685.5M | $581.1M | $668.2M | $872.1M | $1.2B | |
| Revenue (Reported) | $4.2B | $4.8B | $4.2B | $3.9B | $4B | |
| Operating Income (Reported) | $575.4M | $481.7M | $525.8M | $702.9M | $1B | |
| Operating Income (Adjusted) | $685.5M | $581.1M | $668.2M | $872.1M | $1.2B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1B | $1B | $945.9M | $1B | |
| Revenue Growth (YoY) | 33.4% | -13.32% | -2.1% | -7.57% | 6.9% | |
| Cost of Revenues | $825.8M | $752.6M | $685.1M | $558.6M | $565.5M | |
| Gross Profit | $380.1M | $292.6M | $338.2M | $387.3M | $445.6M | |
| Gross Profit Margin | 31.52% | 28% | 33.05% | 40.94% | 44.07% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $239.7M | $211.1M | $179.6M | $158.8M | $157.1M | |
| Other Inc / (Exp) | -$4.5M | $15.9M | $11.4M | $3.9M | $338.6M | |
| Operating Expenses | $224.1M | $211.1M | $179.6M | $158.8M | $157.1M | |
| Operating Income | $156M | $81.5M | $158.7M | $228.5M | $288.5M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $170.5M | $116.3M | $199.7M | $267.1M | $664.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $19.6M | $14.2M | $24.4M | $53.2M | $61.3M | |
| Net Income to Company | $170.5M | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$8.2M | -$6.3M | -$7.6M | -$15.1M | -$13.3M | |
| Net Income to Common Excl Extra Items | $142.7M | $95.8M | $167.7M | $198.7M | $589.8M | |
| Basic EPS (Cont. Ops) | $0.09 | $0.06 | $0.11 | $0.13 | $0.38 | |
| Diluted EPS (Cont. Ops) | $0.08 | $0.06 | $0.11 | $0.13 | $0.38 | |
| Weighted Average Basic Share | $1.7B | $1.6B | $1.6B | $1.5B | $1.5B | |
| Weighted Average Diluted Share | $1.7B | $1.7B | $1.6B | $1.6B | $1.5B | |
| EBITDA | $209.1M | $121M | $204.7M | $271.3M | $667.9M | |
| EBIT | $175.2M | $121M | $204.7M | $271.3M | $667.9M | |
| Revenue (Reported) | $1.2B | $1B | $1B | $945.9M | $1B | |
| Operating Income (Reported) | $156M | $81.5M | $158.7M | $228.5M | $288.5M | |
| Operating Income (Adjusted) | $175.2M | $121M | $204.7M | $271.3M | $667.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.5B | $4.7B | $4.2B | $3.9B | $4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $3.1B | $3.3B | $2.8B | $2.4B | $2.3B | |
| Gross Profit | $1.4B | $1.4B | $1.3B | $1.4B | $1.7B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $883.5M | $1B | $795M | $688.9M | $650M | |
| Other Inc / (Exp) | $7.7M | $12.3M | $34.9M | $13.4M | $362.7M | |
| Operating Expenses | $830.9M | $936.5M | $750.6M | $661.8M | $637.5M | |
| Operating Income | $616.9M | $432.3M | $594.5M | $772.2M | $1.1B | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $697.2M | $507.9M | $728.2M | $921.7M | $1.6B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $66.6M | $59.1M | $89M | $145.2M | $231.4M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$11.4M | -$26.9M | -$25.3M | -$49.7M | -$63M | |
| Net Income to Common Excl Extra Items | $619.2M | $421.8M | $613.9M | $726.8M | $1.3B | |
| Basic EPS (Cont. Ops) | $0.32 | $0.26 | $0.39 | $0.47 | $0.86 | |
| Diluted EPS (Cont. Ops) | $0.31 | $0.25 | $0.38 | $0.46 | $0.85 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $747.4M | $526.5M | $745.5M | $938.5M | $1.6B | |
| EBIT | $713.5M | $526.5M | $745.5M | $938.5M | $1.6B | |
| Revenue (Reported) | $4.5B | $4.7B | $4.2B | $3.9B | $4B | |
| Operating Income (Reported) | $616.9M | $432.3M | $594.5M | $772.2M | $1.1B | |
| Operating Income (Adjusted) | $713.5M | $526.5M | $745.5M | $938.5M | $1.6B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1B | $1B | $945.9M | $1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $825.8M | $752.6M | $685.1M | $558.6M | $565.5M | |
| Gross Profit | $380.1M | $292.6M | $338.2M | $387.3M | $445.6M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $239.7M | $211.1M | $179.6M | $158.8M | $157.1M | |
| Other Inc / (Exp) | -$4.5M | $15.9M | $11.4M | $3.9M | $338.6M | |
| Operating Expenses | $224.1M | $211.1M | $179.6M | $158.8M | $157.1M | |
| Operating Income | $156M | $81.5M | $158.7M | $228.5M | $288.5M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $170.5M | $116.3M | $199.7M | $267.1M | $664.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $19.6M | $14.2M | $24.4M | $53.2M | $61.3M | |
| Net Income to Company | $170.5M | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$8.2M | -$6.3M | -$7.6M | -$15.1M | -$13.3M | |
| Net Income to Common Excl Extra Items | $142.7M | $95.8M | $167.7M | $198.7M | $589.8M | |
| Basic EPS (Cont. Ops) | $0.09 | $0.06 | $0.11 | $0.13 | $0.38 | |
| Diluted EPS (Cont. Ops) | $0.08 | $0.06 | $0.11 | $0.13 | $0.38 | |
| Weighted Average Basic Share | $1.7B | $1.6B | $1.6B | $1.5B | $1.5B | |
| Weighted Average Diluted Share | $1.7B | $1.7B | $1.6B | $1.6B | $1.5B | |
| EBITDA | $209.1M | $121M | $204.7M | $271.3M | $667.9M | |
| EBIT | $175.2M | $121M | $204.7M | $271.3M | $667.9M | |
| Revenue (Reported) | $1.2B | $1B | $1B | $945.9M | $1B | |
| Operating Income (Reported) | $156M | $81.5M | $158.7M | $228.5M | $288.5M | |
| Operating Income (Adjusted) | $175.2M | $121M | $204.7M | $271.3M | $667.9M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.7B | $1B | $1.4B | $1.9B | $1.8B | |
| Short Term Investments | $2.3B | $2.2B | $1.6B | $1.4B | $1.9B | |
| Accounts Receivable, Net | $428.6M | $566.4M | $387M | $411.6M | $480.5M | |
| Inventory | $2.8M | $3.8M | $2M | $1.1M | $3.2M | |
| Prepaid Expenses | $398.7M | $390.3M | $384.4M | $336.7M | $332.7M | |
| Other Current Assets | $8.1M | $8.8M | $7.7M | $8M | $10M | |
| Total Current Assets | $4.9B | $4.2B | $3.8B | $4.2B | $4.7B | |
| Property Plant And Equipment | $74.5M | $82.5M | $104.5M | $120.9M | $150.4M | |
| Long-Term Investments | $2.3B | $2.4B | $2.1B | $2.8B | $4.1B | |
| Goodwill | $2.7B | $3B | $2.8B | $2.8B | $2.7B | |
| Other Intangibles | $309.2M | $678.4M | $702.7M | $630.5M | $604.5M | |
| Other Long-Term Assets | -- | -- | $15.4M | $15.5M | $14M | |
| Total Assets | $10.5B | $10.6B | $9.7B | $10.7B | $12.4B | |
| Accounts Payable | $545.7M | $679.2M | $724.4M | $706.2M | $942.3M | |
| Accrued Expenses | $415.9M | $491.5M | $409.5M | $307.4M | $314.9M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | $295.1M | |
| Current Portion Of Capital Lease Obligations | $15.8M | $14.4M | $17.8M | $16.2M | $14.5M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.5B | $1.6B | $1.7B | $1.7B | $2.3B | |
| Long-Term Debt | $792.1M | $794.2M | $802.4M | $795.1M | $489.3M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.4B | $2.5B | $2.6B | $2.6B | $2.8B | |
| Common Stock | $306.1K | $313.8K | $289.9K | $282.1K | $274K | |
| Other Common Equity Adj | $964.3M | $584.6M | $889.9M | $1.4B | $2.7B | |
| Common Equity | $8B | $7.9B | $7B | $7.9B | $9.3B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $74.4M | $115.8M | $149M | $182.7M | $255.2M | |
| Total Equity | $8.1B | $8B | $7.1B | $8.1B | $9.6B | |
| Total Liabilities and Equity | $10.5B | $10.6B | $9.7B | $10.7B | $12.4B | |
| Cash and Short Terms | $4B | $3.2B | $3B | $3.3B | $3.7B | |
| Total Debt | $792.1M | $794.2M | $802.4M | $795.1M | $784.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.6B | $1.3B | $1.8B | $1.4B | $1.7B | |
| Short Term Investments | $2B | $1.8B | $1.2B | $2.3B | $2B | |
| Accounts Receivable, Net | $428M | $395.3M | $395.5M | $394.6M | $440.7M | |
| Inventory | $2.7M | $3.6M | $1.7M | $1.5M | $2.5M | |
| Prepaid Expenses | $389.5M | $423.1M | -- | $431.1M | $585.8M | |
| Other Current Assets | -- | -- | $374.8M | -- | -- | |
| Total Current Assets | $4.4B | $4B | $3.8B | $4.6B | $4.7B | |
| Property Plant And Equipment | $72.5M | $81M | $102M | $118.5M | $164.8M | |
| Long-Term Investments | $2.4B | $2.3B | $2.5B | $2.9B | $5.2B | |
| Goodwill | $2.9B | $3B | $2.8B | $2.7B | $2.7B | |
| Other Intangibles | $387.6M | $822.2M | $690.4M | $624.2M | $602.2M | |
| Other Long-Term Assets | $146.9M | $106.2M | $87M | $61.4M | $43M | |
| Total Assets | $10.3B | $10.4B | $10B | $11.1B | $13.5B | |
| Accounts Payable | $594.8M | $814.6M | $773M | $771.9M | $1B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | $296.3M | |
| Current Portion Of Capital Lease Obligations | $16.6M | $13.5M | $16.7M | $13.6M | $14.3M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.4B | $1.7B | $1.6B | $1.7B | $2.6B | |
| Long-Term Debt | $792M | $792.9M | $793.8M | $793.5M | $491.2M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.3B | $2.6B | $2.5B | $2.6B | $3.2B | |
| Common Stock | $303.9K | $314.6K | $290.6K | $281K | $275.3K | |
| Other Common Equity Adj | $748.9M | $202.9M | $1.1B | $1.7B | $3.2B | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $80.8M | $124.1M | $157.4M | $202.2M | $270.1M | |
| Total Equity | $8B | $7.7B | $7.6B | $8.5B | $10.4B | |
| Total Liabilities and Equity | $10.3B | $10.4B | $10B | $11.1B | $13.5B | |
| Cash and Short Terms | $3.6B | $3.2B | $3B | $3.7B | $3.7B | |
| Total Debt | $792M | $792.9M | $793.8M | $793.5M | $787.5M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $671.2M | $562.5M | $651M | $854.6M | $1.2B | |
| Depreciation & Amoritzation | $119.4M | $155M | $172.7M | $141.9M | $136.3M | |
| Stock-Based Compensation | $82.5M | $100.2M | $99M | $91.7M | $83.1M | |
| Change in Accounts Receivable | -$75.4M | -$119.1M | $134.9M | -$28.8M | -$75.1M | |
| Change in Inventories | $1.2M | -$929.3K | $1.5M | $989.6K | -$2.1M | |
| Cash From Operations | $707.9M | $811.4M | $1.1B | $1B | $1.4B | |
| Capital Expenditures | $72.6M | $427.2M | $156.8M | $164.6M | $143.8M | |
| Cash Acquisitions | -$76.1M | -$321.4M | -$21.4M | $8.1M | -$5.7M | |
| Cash From Investing | -$2.1B | -$929.1M | -$215.3M | -$263.4M | -$950.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -$210.2M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $783.9M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$11.6M | -$18M | -$19.4M | -$16.4M | -$18.7M | |
| Repurchase of Common Stock | -$19.4M | -$538.8M | -$465.5M | -$176.6M | -$268.3M | |
| Other Financing Activities | -$869.4K | -$3.4M | -$5.2M | -$9.2M | -$11.6M | |
| Cash From Financing | $766.8M | -$574.6M | -$509M | -$217.4M | -$533.8M | |
| Beginning Cash (CF) | $2.2B | $1.7B | $981.2M | $1.4B | $1.9B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$583.8M | -$692.3M | $389.5M | $556.4M | -$52M | |
| Ending Cash (CF) | $1.6B | $1B | $1.4B | $1.9B | $1.8B | |
| Levered Free Cash Flow | $635.3M | $384.3M | $957M | $872.7M | $1.3B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $170.5M | -- | -- | -- | -- | |
| Depreciation & Amoritzation | $33.9M | -- | -- | -- | -- | |
| Stock-Based Compensation | $23.3M | -- | -- | -- | -- | |
| Change in Accounts Receivable | $1.5M | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $289.4M | $392.4M | $270.6M | $375.4M | $346.3M | |
| Capital Expenditures | $30.8M | -- | -- | -- | -- | |
| Cash Acquisitions | -$319.2M | -- | -- | -- | -- | |
| Cash From Investing | -$367.1M | -$51.8M | $118.5M | -$768.4M | -$442.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$3.5M | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$50.4M | -- | -- | -- | -- | |
| Other Financing Activities | -$1.5M | -- | -- | -- | -- | |
| Cash From Financing | -$57.3M | -$62.1M | -$11.7M | -$73M | -$62.7M | |
| Beginning Cash (CF) | $1.7B | $1B | $1.4B | $1.9B | $1.8B | |
| Foreign Exchange Rate Adjustment | $3.4M | -$1.3M | -$1.3M | -$2.1M | $2.2M | |
| Additions / Reductions | -$135M | $278.5M | $377.4M | -$466M | -$159.2M | |
| Ending Cash (CF) | $1.6B | $1.3B | $1.8B | $1.4B | $1.7B | |
| Levered Free Cash Flow | $258.6M | $392.4M | $270.6M | $375.4M | $346.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | $23.3M | $76.9M | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $844.6M | $914.3M | $992M | $1.1B | $1.4B | |
| Capital Expenditures | $30.8M | $396.3M | -- | -- | -- | |
| Cash Acquisitions | -$319.2M | -$2.2M | -- | -- | -- | |
| Cash From Investing | -$1.8B | -$613.8M | -$45M | -$1.2B | -$624.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $728.3M | -$579.4M | -$458.5M | -$278.7M | -$523.5M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$266.1M | -$278.8M | $488.4M | -$286.9M | $254.8M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $813.8M | $914.3M | $992M | $1.1B | $1.4B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $170.5M | -- | -- | -- | -- | |
| Depreciation & Amoritzation | $33.9M | -- | -- | -- | -- | |
| Stock-Based Compensation | $23.3M | -- | -- | -- | -- | |
| Change in Accounts Receivable | $1.5M | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $289.4M | $392.4M | $270.6M | $375.4M | $346.3M | |
| Capital Expenditures | $30.8M | -- | -- | -- | -- | |
| Cash Acquisitions | -$319.2M | -- | -- | -- | -- | |
| Cash From Investing | -$367.1M | -$51.8M | $118.5M | -$768.4M | -$442.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$3.5M | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$50.4M | -- | -- | -- | -- | |
| Other Financing Activities | -$1.5M | -- | -- | -- | -- | |
| Cash From Financing | -$57.3M | -$62.1M | -$11.7M | -$73M | -$62.7M | |
| Beginning Cash (CF) | $1.7B | $1B | $1.4B | $1.9B | $1.8B | |
| Foreign Exchange Rate Adjustment | $3.4M | -$1.3M | -$1.3M | -$2.1M | $2.2M | |
| Additions / Reductions | -$135M | $278.5M | $377.4M | -$466M | -$159.2M | |
| Ending Cash (CF) | $1.6B | $1.3B | $1.8B | $1.4B | $1.7B | |
| Levered Free Cash Flow | $258.6M | $392.4M | $270.6M | $375.4M | $346.3M | |
Get TME Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
TME
Sector
P/E ratio
25.31x
17.70x
PEG ratio
0.31x
0.00x
P/B ratio
3.28x
1.49x
Price / LTM sales
8.32x
0.96x
Growth Metrics
TME
Sector
Revenue growth
6.9%
-0.53%
Earnings growth
197.21%
-0.61%
Revenue (5-year growth)
1.46%
1.59%
Earnings forecast
$0.20
$0.05
Profitability
TME
Sector
Profitability FY 2024
$1.7B
$256.3M
Return on invested capital
13.08%
0.79%
Return on assets
10.9%
0.12%
Return on equity
14.19%
2.1%
Earnings Date
Last Earnings Date
May
13
Next Earnings Date
Aug
12
Estimated Next Earnings Date
Aug
12
Balance Sheet
TME
Sector
Total cash
$3.7B
$97.1M
Short term investments
$1.9B
$26.8M
Total assets
$12.4B
$827.5M
Long term debt
$787.5M
$44M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 3.58% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.66% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 8.31% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
